We look forward to working with Ascendis to explore the potential of the TransCon technology platform to reduce the dosing frequency of GLP-1 receptor agonists and other treatments for cardiometabolic diseases. According to Ascendis, TransCon is a drug development platform that uses advanced chemistry to overcome known challenges in developing therapeutics
Inject the 8.5mL of solution into the sterile vial 6
Factors including metabolic biomarkers, kidney function, gastrointestinal history, and personal medical goals should guide whether this therapy is right for you
up to 4 cm length 64891 Nerve graft (includes obtaining graft), single strand, hand or foot
Multiple testing options with rapid results for COVID-19 exposure or symptoms
Cortisol ramps up ghrelin (the Im hungry hormone) and dulls leptin (the Im full signal), making you crave sugary or fatty foodslike reaching for chips during a tough day